Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Takafumi Handa"'
Autor:
Ayako Ura, Takuo Hayashi, Kazumasa Komura, Masaki Hosoya, Kazuya Takamochi, Eiichi Sato, Satomi Saito, Susumu Wakai, Takafumi Handa, Tsuyoshi Saito, Shunsuke Kato, Kenji Suzuki, Takashi Yao, the Tokyo Metropolitan Innovative Oncology Research Group (TMIG)
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 1, Pp n/a-n/a (2024)
Abstract A limited number of patients with lung squamous cell carcinoma (SCC) benefit clinically from molecular targeted drugs because of a lack of targetable driver alterations. We aimed to understand the prevalence and clinical significance of lysi
Externí odkaz:
https://doaj.org/article/d74d3a6bf28241e39e1c5855f8cdaf80
Autor:
Takafumi Handa, Takuo Hayashi, Ayako Ura, Isamu Watanabe, Kazuya Takamochi, Hiroko Onagi, Monami Kishi, Naohisa Matsumoto, Ken Tajima, Satsuki Kishikawa, Tsuyoshi Saito, Kazuhisa Takahashi, Kenji Suzuki, Takashi Yao
Publikováno v:
Histopathology. 82:860-869
Autor:
Satsuki, Kishikawa, Takuo, Hayashi, Kazuya, Takamochi, Shiori, Takekawa, Noriko, Sasahara, Takafumi, Handa, Tsuyoshi, Saito, Kenji, Suzuki, Takashi, Yao
Publikováno v:
Histopathology. 82:264-275
Bronchiolar adenoma (BA) is a novel entity in the 2021 WHO classification of lung tumours. The expression profile of mucin core proteins in BAs is not clear. The aim of this study was to clarify the expression profiles of mucins and to validate the c
Autor:
Satsuki Kishikawa, Takuo Hayashi, Kazuya Takamochi, Shiori Takekawa, Noriko Sasahara, Takafumi Handa, Tsuyoshi Saito, Kenji Suzuki, Takashi Yao
Publikováno v:
Histopathology; Jan2023, Vol. 82 Issue 2, p264-275, 12p